Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

What Makes A Healthcare Pioneer? Senator Richard Blumenthal, Lyme Disease Advocacy Giant, Salutes Researcher to be Honored April 2, 2016
  • USA - English


News provided by

Global Lyme Alliance

Mar 01, 2016, 15:20 ET

Share this article

Share toX

Share this article

Share toX

Senator Blumenthal at last year's "Time for Lyme" Gala
Senator Blumenthal at last year's "Time for Lyme" Gala

GREENWICH, Connecticut (PRWEB) March 01, 2016 -- Thousands in the Lyme disease community hail U.S. Senator Richard Blumenthal (D-CT) as a pioneer for the cause, who has worked for nearly 20 years with Global Lyme Alliance. Some of the highlights of his advocacy work:

The Gala celebrates efforts of incredible individuals in the Lyme disease field.

Post this
  • Ten years ago, as Attorney General, Blumenthal launched an investigation into guidelines for treating Lyme developed by the Infectious Diseases Society of America (IDSA). The guidelines, which advised against antibiotic treatments beyond four weeks, favored insurers by restricting coverage for long-term treatment.
  • Then, five years ago, Blumenthal announced he would introduce a bill in the U.S. Senate aimed at promoting better diagnosis, reporting and research on Lyme disease. Since then he has been unrelenting in his determination to increase public awareness and strengthen efforts to combat tick-borne diseases.
  • Last summer, in his latest push for passage of Lyme legislation, he introduced S.1503, “The Lyme and Tick-Borne Disease Prevention, Education and Research Act” which calls on HHS to develop better tools for diagnosing and reporting the illness, treatment and the exploration of vaccines. He hopes the bill will pass during this legislative session. 

This week, Blumenthal turned the spotlight on someone he described as a “true pioneer in the study of chronic Lyme disease” and he should know. He saluted Dr. Brian Fallon, director of the Lyme and Tick-Borne Disease Research Center at Columbia University Medical Center, who will be honored with the Lauren F. Brooks Hope Award at Global Lyme Alliance’s (GLA) “Time for Lyme” Gala, April 2, in Old Greenwich, Connecticut. 

“It’s an honor to be part of this year’s Gala to celebrate efforts of incredible individuals in the field—especially Dr. Brian Fallon,” the Senator said. Blumenthal, who has worked closely with Global Lyme Alliance over the years, added: “I look forward to continuing my partnership with the Global Lyme Alliance in the fight to eradicate this pernicious public health threat.”

Said GLA Vice Chair Diane Blanchard, who has worked with Dr. Fallon for nearly two decades: “We proudly honor Dr. Fallon who is recognized internationally for his research on neuropsychiatric aspects of Lyme and tick-borne diseases. He accomplished a lot of his work when Lyme disease research was not popular and was even risky for one’s career.”

“We also thank Senator Blumenthal for being there in the early years when Global Lyme Alliance was but a dream toward which we were striving,” Blanchard said. “I still remember when the Senator first announced plans for his Lyme disease bill. I’m proud to say that his commitment to improving the lives of Lyme disease patients and being a friend to GLA has never wavered.”

The “Time for Lyme” Gala is a major fundraising event for Global Lyme Alliance, a leading Lyme and tick-borne disease nonprofit. The gala will be held Saturday, April 2, 2016 from 6:30 p.m. to midnight at the Hyatt Regency Greenwich in Old Greenwich, CT. It features a cocktail reception, dinner, dancing, and both silent and live auctions. For more information, or to purchase tables or tickets, please visit GlobalLymeAlliance.org or call 203-969-1333.  

ABOUT GLOBAL LYME ALLIANCE
Global Lyme Alliance funds cutting-edge research at leading U.S. universities for the purpose of developing reliable diagnostic tools, effective treatments and ultimately curing Lyme disease, while building greater public awareness for disease detection and prevention. A 503 (c)(3), GLA is headquartered in Greenwich, CT. For more information please visit GlobalLymeAlliance.org or call 203-969-1333.

Rona Cherry, Global Lyme Alliance, http://www.lymeresearchalliance.org, +1 212-586-0917, [email protected]

Modal title

Dr. Brian A. Fallon
Dr. Brian A. Fallon
Dr. Brian A. Fallon

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.